HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma
Open Access
- 21 June 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 111 (3), 618-626
- https://doi.org/10.1002/jcb.22742
Abstract
Cadherin-17 (CDH17) belongs to the cell adhesion cadherin family with a prominent role in tumorigenesis. It is highly expressed in human hepatocellular carcinoma (HCC) and is proposed to be a biomarker and therapeutic molecule for liver malignancy. The present study aims to identify the transcription factors which interact and regulate CDH17 promoter activity that might contribute to the up-regulation of CDH17 gene in human HCC. A 1-kb upstream sequence of CDH17 gene was cloned and the promoter activity was studied by luciferase reporter assay. By bioinformatics analysis, deletion and mutation assays, and chromatin immunoprecipitation studies, we identified hepatic nuclear factor 1α (HNF1α) and caudal-related homeobox 2 (CDX2) binding sites at the proximal promoter region which modulate the CDH17 promoter activities in two HCC cell lines (Hep3B and MHCC97L). A consistent down-regulation of CDH17 and the two transcriptional activators (HNF1α and CDX2) expression was found in the liver of mouse during development, as well as in human liver cancer cells with less metastatic potential. Suppression of HNF1α and CDX2 expression by small interfering RNA (siRNA) significantly down-regulated expressions of CDH17 and its downstream target cyclin D1 and the viability of HCC cells in vitro. In summary, we identified the minimal promoter region of CDH17 that is regulated by HNF1α and CDX2 transcriptional factors. The present findings enhance our understanding on the regulatory mechanisms of CDH17 oncogene in HCC, and may shed new insights into targeting CDH17 expression as potential therapeutic intervention for cancer treatment. J. Cell. Biochem. 111: 618–626, 2010.Keywords
This publication has 36 references indexed in Scilit:
- Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parametersBMC Cancer, 2009
- Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinomaHepatology, 2009
- Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJCI Insight, 2006
- Functional mapping of tissue-specific elements of the human α-fetoprotein gene enhancerBiochemical and Biophysical Research Communications, 2004
- Identification of liver–intestine cadherin in hepatocellular carcinoma—a potential disease markerBiochemical and Biophysical Research Communications, 2003
- Lewis Type 1 Antigen Synthase (β3Gal-T5) Is Transcriptionally Regulated by HomeoproteinsOnline Journal of Public Health Informatics, 2003
- Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreasCancer Science, 2003
- Regulation of kidney-specific Ksp-cadherin gene promoter by hepatocyte nuclear factor-1βAmerican Journal of Physiology-Renal Physiology, 2002
- LI‐cadherin gene expression during mouse intestinal developmentDevelopmental Dynamics, 2001
- Expression of HNF-1α and HNF-1β in various histological differentiations of hepatocellular carcinomaThe Journal of Pathology, 1998